Life Sciences Companies Face Continuing Compliance Challenges in Developing Value-Based and Value-Added Models
McGuireWoods – The HHS Office of Inspector General's unfavorable Advisory Opinion 23-08 continues its long-held position that the provision of value-added items and services implicates fraud and abuse laws, including the Federal Anti-Kickback Statute and the Beneficiary Inducement Civil Monetary Penalty law.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.